The role of radiation in urological malignancies

Eric D. Donnelly, Bryan David Macrie*

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Radiation therapy (RT) is a vital component of treatment for many urologic malignancies including prostate cancer, where advancements in RT technique have improved outcomes without adding toxicity. In bladder cancers, use of concurrent chemoradiation therapy and surgery for salvage has yielded survival equivalent to up-front cystectomy with preservation of the bladder. In patients with stage I-II testicular seminomas, RT utilization has been refined to limit unnecessary exposure. The role of RT is not well defined in the management of penile and urethral cancers; however, the literature supports its use as an organ-preserving treatment approach.

Original languageEnglish (US)
Title of host publicationRadiation Therapy for Pelvic Malignancy and its Consequences
PublisherSpringer New York
Pages41-51
Number of pages11
ISBN (Electronic)9781493922178
ISBN (Print)9781493922161
DOIs
StatePublished - Jan 1 2015

Keywords

  • Brachytherapy
  • Chemoradiation therapy
  • Genitourinary cancer
  • Radiation therapy
  • Urologic malignancy

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'The role of radiation in urological malignancies'. Together they form a unique fingerprint.

  • Cite this

    Donnelly, E. D., & Macrie, B. D. (2015). The role of radiation in urological malignancies. In Radiation Therapy for Pelvic Malignancy and its Consequences (pp. 41-51). Springer New York. https://doi.org/10.1007/978-1-4939-2217-8_2